Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novo Nordisk A/S ADR (NVO)

Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 606,534,912
  • Shares Outstanding, K 4,487,532
  • Annual Sales, $ 33,724 M
  • Annual Income, $ 12,151 M
  • 60-Month Beta 0.43
  • Price/Sales 17.69
  • Price/Cash Flow 43.80
  • Price/Book 41.10
Trade NVO with:

Options Overview Details

View History
  • Implied Volatility 24.98% ( +0.17%)
  • Historical Volatility 23.08%
  • IV Percentile 14%
  • IV Rank 11.16%
  • IV High 44.88% on 08/03/23
  • IV Low 22.48% on 06/13/23
  • Put/Call Vol Ratio 0.42
  • Today's Volume 10,858
  • Volume Avg (30-Day) 20,843
  • Put/Call OI Ratio 0.69
  • Today's Open Interest 241,699
  • Open Int (30-Day) 261,859

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.83
  • Number of Estimates 3
  • High Estimate 0.85
  • Low Estimate 0.82
  • Prior Year 0.63
  • Growth Rate Est. (year over year) +31.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
121.29 +10.53%
on 05/03/24
135.48 -1.05%
on 05/21/24
+8.80 (+7.03%)
since 04/22/24
3-Month
118.91 +12.74%
on 02/29/24
138.28 -3.05%
on 03/07/24
+9.54 (+7.66%)
since 02/22/24
52-Week
75.56 +77.42%
on 07/11/23
138.28 -3.05%
on 03/07/24
+48.80 (+57.24%)
since 05/22/23

Most Recent Stories

More News
Novo Nordisk's Stock Dips After Second Fire Hits Danish Facilities

Novo Nordisk (NVO), the maker of popular weight-loss and diabetes treatments Ozempic and Wegovy, experienced a significant fire at its Danish headquarters in Bagsvaerd, marking the second blaze to impact...

NVO : 133.70 (-1.08%)
Is Novo Nordisk Stock a Millionaire Maker?

Novo Nordisk's stock may look expensive today, but that may not be the case in even a year or two.

NVO : 133.70 (-1.08%)
Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk

Could Amgen be the next stock to soar due to a GLP-1 drug?

NVO : 133.70 (-1.08%)
LLY : 798.35 (-0.60%)
AMGN : 313.33 (-0.48%)
If You'd Invested $1,000 in Novo Nordisk Stock 5 Years Ago, Here's How Much You'd Have Today

Back then, the company wasn't very well known to U.S. investors. That's absolutely not the case these days.

NVO : 133.70 (-1.08%)
Novo Nordisk Bets Up to $600 Million on Ozempic 2.0. Here's Why the Stock Is a Buy.

This company is serious about maintaining its leadership.

NVO : 133.70 (-1.08%)
2 Top Pharma Stocks That Just Keep Getting Better and Better

Both of these businesses are finding traction in a pair of major markets.

LLY : 798.35 (-0.60%)
NVO : 133.70 (-1.08%)
1 'Strong Buy' Dividend Stock to Buy and Hold

Discover why Eli Lilly is considered a 'strong buy' as it capitalizes on the growing demand for diabetes and obesity treatments, backed by its robust financial performance and promising future prospects....

LLY : 798.35 (-0.60%)
NVO : 133.70 (-1.08%)
How Viking Therapeutics Stock Could 30x

This mid-cap biopharma may one day be a titan of the industry.

LLY : 798.35 (-0.60%)
NVO : 133.70 (-1.08%)
VKTX : 62.70 (-2.38%)
PFE : 29.29 (+2.56%)
Forget Weight-Loss Drugs, Here's the Next Breakthrough Pharma Stock

There is another segment of the pharma industry that is as hot as weight-loss drugs: antibody-drug conjugates, or ADCs. These treatments will, in the near future, replace conventional chemotherapy, thanks...

PFE : 29.29 (+2.56%)
ABBV : 160.69 (-1.37%)
JNJ : 153.80 (+1.69%)
RHHBY : 31.8100 (-1.58%)
GMAB : 29.89 (+2.54%)
AZN : 78.82 (-0.45%)
DSNKY : 34.6250 (-1.38%)
MRK : 131.13 (+0.28%)
LLY : 798.35 (-0.60%)
NVO : 133.70 (-1.08%)
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?

These stocks are both experts in their respective fields.

PFE : 29.29 (+2.56%)
NVO : 133.70 (-1.08%)
EXEL : 21.19 (+0.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Bagsv'rd, Denmark-based Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market. The company is also a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity.Novo Nordisk operates through two segments: Diabetes and obesity care...

See More

Key Turning Points

3rd Resistance Point 138.15
2nd Resistance Point 136.81
1st Resistance Point 135.99
Last Price 133.70
1st Support Level 133.83
2nd Support Level 132.49
3rd Support Level 131.67

See More

52-Week High 138.28
Last Price 133.70
Fibonacci 61.8% 114.32
Fibonacci 50% 106.92
Fibonacci 38.2% 99.52
52-Week Low 75.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar